Small-Molecule Drug (Drug Discovery) Equipment
-
Manufactured by Acousia Therapeutics GmbHbased in GERMANY
With its first clinical study underway, Acousia is taking significant strides towards achieving its goal of developing novel medicines that enhance and preserve natural hearing for patients with ...
-
Manufactured by Gerresheimer AGbased in GERMANY
The on-body infusor for the subcutaneous application of small-molecule drugs is available for volumes up to 3 ml. It can be worn on the body. Typical applications are bolus and basal regimens over several ...
-
Manufactured by Symberix, Inc.based in USA
Symberix is advancing a portfolio of first-in-class drug candidates for multiple adjunct and monotherapeutic indications. Our discovery platform enables precise targeting of bacteria implicated in intestinal toxicity and gastrointestinal disease. By identifying specific bacterial enzyme targets, we can develop small molecule ...
-
Manufactured by Bayer AGbased in GERMANY
Traditionally, many small molecule drugs follow the same basic mechanism of action to treat diseases: They inhibit the function of a target protein that has an active role in a disease. To do so, they require a tractable active binding site to occupy, which will result in protein function inhibition like blocking its enzymatic ...
-
Manufactured by Gerresheimer AGbased in GERMANY
This belt-worn on-body drug delivery device for small-molecule drugs has been developed for our pharma partner EVER Pharma. The wearable device is used by Parkinson's disease patients for the administration of apomorphine to treat this long-term degenerative disorder of the central nervous system. This device is customizable to ...
-
Manufactured by Jericho Sciences, LLCbased in USA
Jericho is developing a new therapeutic drug for FIV infection in cats, working toward a New Animal Drug Application (NADA) with the FDA. Our ongoing studies indicate that Jericho’s small molecule drug candidate can reduce FIV virus levels in chronically-infected cats for many months in the absence of ...
-
based in USA
The Alucent NVS Vessel Restoration System is designed to create a natural, stent-like scaffold using the body’s own tissue and processes. An all-in-one, integrated procedural system, Alucent NVS combines standard angioplasty techniques with a small molecule drug that when photoactivated, promotes extracellular matrix protein linking ...
-
based in AUSTRALIA
DEP® radiotheranostic conjugates have the potential to minimise off-target toxicity, optimise pharmacokinetics and enhance efficacy when used alone or in combination with other therapeutic approaches. The versatility of Starpharma’s DEP® platform means it can be used with a wide range of therapies and types of molecules (e.g., ...
-
Manufactured by ApiJect Systems, Corp.based in USA
Blow-Fill-Seal (BFS) is a globally-trusted aseptic packaging technology where the pharmaceutical-grade plastic container is made, filled with the liquid drug product, and sealed in a rapid, continuous process. BFS is used around the world to package billions of doses of both large and small molecule sterile drug products ...
-
Manufactured by Krieger AGbased in SWITZERLAND
With a starting minimum volume of 25 ml, the Micro Mixer range is the ideal tool to scale down your contained mixing processes under pressure or vacuum. Dissolution of expensive shear sensitive API's, proteins, Developing and processing small molecule and complex biologic drug candidates. Or just vacuum ...
-
by DEARGEN Inc.based in SOUTH KOREA
Dr. UG is an AI platform for developing new drugs that is based on DEARGEN’s deep learning technology. It specializes in genome data analysis, biomarker prediction, molecule selection and optimization. DEARGEN discovers new disease targets with Dr.UG and further realizes precision medicine by designing small molecules for ...
-
Manufactured by Lanthio Pharma BVbased in NETHERLANDS
Peptides are an increasingly important class of drug. As natural ligands to many targets, they can combine agonistic or antagonistic activity with low toxicity risk and can be applied to disease targets, where small molecules or antibody-based drugs cannot be used. However, the number of therapeutic peptide drugs ...
-
based in ITALY
In Silico: Identifying small molecules able to revolutionize drug discovery. The PPI-FIT technology allows the exploration of unique pharmacological targets represented by protein folding intermediates. This places Sibylla Biotech in the exclusive position of identifying hit/lead compounds with a mechanism of action never explored so ...
-
Manufactured by Cytenabased in GERMANY
Featuring Immediate Drop-on-demand Technology (I.DOT), the lightweight I.DOT Mini optimizes noncontact liquid handling tasks to bring intuitive automation, precision and speed to every lab in a smaller footprint. ...
-
Manufactured by SomaGenics, Inc.based in USA
RNA interference (RNAi) is a naturally occurring process by which RNA molecules inhibit gene expression either pre- or post-transcriptionally. The discovery of RNAi led to a better understanding of gene regulation and opened the door to exciting new applications in research and therapeutics. The 2006 Nobel price was awarded in ...
-
based in AUSTRALIA
Starpharma’s DEP® technology provides enhanced therapeutic benefits to Antibody Drug Conjugates (ADCs) including greater homogeneity, site specific attachment, and higher drug antibody ratio (DAR), than conventional ADC approaches. The use of ADCs is an innovative and cutting-edge area in cancer therapy that continues to ...
-
Manufactured by Symberix, Inc.based in USA
A microbiome is a collection of microorganisms (and their DNA) that occupy a particular location. The "human microbiome" is composed of trillions of tiny microbes (mostly bacteria) that thrive in our mouth, on our skin, and inside our gut. An individual's gut microbiome is a unique and diverse community of thousands of distinct bacterial species. The vast majority of these bacteria are not ...
-
based in AUSTRALIA
An i-body is a human protein that belongs to the class of next generation antibodies. The i-body is built on the scaffold of a human protein and engineered with two loops that mimic the shape of shark antibodies. These loops are responsible for binding or interacting with a particular target (in circulation or on a cell) that is causing disease. i-bodies are identified and developed using our ...
-
Manufactured by Generex Biotechnology Corporationbased in USA
NuGenerex Therapeutics houses the legacy diabetes assets, Oral-lyn (Buccal Insulin) and RapidMist Buccal delivery technology is a safe, effective, fast, flexible, pain-free and simple alternative to needle administered medications. We believe that our Buccal Delivery Technology is a platform technology that has application for many large ...
-
Manufactured by Juvena Therapeutics, inc.based in USA
Secreted proteins are a proven class of biologics with tremendous therapeutic potential, as they regulate tissue repair and regeneration, organ development, and immune response to disease. The characteristics of secreted proteins render them a rich pool of drug candidates for chronic and age-related diseases. Our therapeutic approach is to ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you